Article

Dr. Niteesh Choudhry Discusses Value-Based Insurance Design [Part 4 of 4]

Dr. Niteesh Choudhry, Associate Professor, Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics in Boston, talks about the overwhelmingly positive feedback he has received from his colleagues about the significance of VBID, even when factoring in the suggested limitations from the myocardial infarction study.

In this segment, Dr. Choudhry discusses how the rigorous research methods that were applied in this VBID study proved valuable in several ways that transcends cost, such as highlighting the magnitude of nonadherence, and the need for physicians to understand that their work isn’t done once they’ve made the decision to prescribe.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Sundar Jagannath
Hadar Avihai Lev-Tov, MD
Ayodeji Adegunsoye, MD, PhD, MSc
David J. Maron, MD, FASPC, Stanford University School of Medicine
Hadar Avihai Lev-Tov, MD
Senator Vincent Polistina (R, New Jersey)
Karen Vo talks about antibullying campaigns and pediatric patients with derm conditions
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo